Intervacc is trading at €0.04, down 24.27%; no company-specific announcement explaining the October 21 move was identified.

  • The latest company update found was a September conference announcement; Q3 results are scheduled for November 12.
  • The supplied biotech-sector rally was in the opposite direction and does not explain the decline.
  • Available information does not establish a clear catalyst or trading-volume explanation.